- Tytuł:
- Efficacy and Safety of Netakimab, A Novel Anti-IL-17 Monoclonal Antibody, in Patients with Moderate to Severe Plaque Psoriasis. Results of A 54-Week Randomized Double-Blind Placebo-Controlled PLANETA Clinical Trial
- Autorzy:
- Źródło:
- Dermatology and Therapy: Research, treatment and aesthetic interventions in dermatology. 11(4):1319-1332
Czasopismo naukowe